Inventor · disambiguated record
Alessandra Del Rio
Also filed as: DEL RIO ALESSANDRA
22 granted patents·14 pending applications·70 citations·filing 2004–2023
94Inventor score
Files withFRESENIUS KABI DEUTSCHLAND GMBH17ARES TRADING SA7MERCK PATENT GMBH3SAMARITANI FABRIZIO3DEL RIO ALESSANDRA2
Top patents by PatentIndex Score
36 records- 0195US10493152B2Adalimumab formulationsFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2015·Granted Dec 3, 2019·10 cites·14 claims
- 0295US10426832B2Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2015·Granted Oct 1, 2019·10 cites·9 claims
- 0394US11752209B2Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2022·Granted Sep 12, 2023·1 cites·11 claims
- 0494US10426833B2Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2015·Granted Oct 1, 2019·10 cites·19 claims
- 0593US10772961B2Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2019·Granted Sep 15, 2020·6 cites·26 claims
- 0688US11707524B2Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2021·Granted Jul 25, 2023·1 cites·11 claims
- 0787US11712471B2Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2020·Granted Aug 1, 2023·1 cites·13 claims
- 0886US11752208B2Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2020·Granted Sep 12, 2023·1 cites·6 claims
- 0986US10961314B2Liquid pharmaceutical composition comprising an anti-IL-6 receptor antibodyFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2017·Granted Mar 30, 2021·6 cites·12 claims
- 1084US12109267B2Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2022·Granted Oct 8, 2024·0 cites·11 claims
- 1179US11058769B2Aqueous pharmaceutical formulation comprising anti-PD-L1 antibody AvelumabMERCK PATENT GMBH·Filed 2016·Granted Jul 13, 2021·2 cites·40 claims
- 1279US8637021B2Formulations for TACI-immunoglobulin fusion proteinsDEL RIO ALESSANDRA·Filed 2008·Granted Jan 28, 2014·5 cites·21 claims
- 1377US7540382B2Stabilized liquid protein formulations in pharmaceutical containersARES TRADING SA·Filed 2004·Granted Jun 2, 2009·8 cites·12 claims
- 1476US2021308262A1Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2021·Application pending·0 cites
- 1576US2021322551A1Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2021·Application pending·0 cites
- 1672US7731948B2Stabilized interferon liquid formulationsARES TRADING SA·Filed 2005·Granted Jun 8, 2010·1 cites·2 claims
- 1772US2024150479A1Liquid Pharmaceutical Composition Comprising an Anti-IL-6 Receptor AntibodyFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2023·Application pending·0 cites
- 1872US2021121566A1Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2020·Application pending·0 cites
- 1971US9512215B2Liquid formulations of tumor necrosis factor-binding proteinsARES TRADING SA·Filed 2014·Granted Dec 6, 2016·0 cites·14 claims
- 2070US9326944B2Freeze-dried formulations of FGF-18CERRETI ALESSANDRA·Filed 2012·Granted May 3, 2016·5 cites·12 claims
- 2167USRE43331EStabilized liquid protein formulations in pharmaceutical containersSAMARITANI FABRIZIO·Filed 2004·Granted May 1, 2012·3 cites·25 claims
- 2264US2020155677A1Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2019·Application pending·0 cites
- 2362US2010261887A1Taci-immunoglobulin fusion proteins for treatment of relapsing multiple sclerosisARES TRADING SA·Filed 2008·Application pending·0 cites
- 2461US8937045B2Liquid formulations of tumor necrosis factor-binding proteinsSAMARITANI FABRIZIO·Filed 2004·Granted Jan 20, 2015·0 cites·10 claims
- 2561US2006160739A1GRF-containing lyophilized pharmaceutical compositionsAPPLIED RESEARCH SYSTEMS·Filed 2006·Application pending·0 cites
- 2660US2021261673A1Liquid Pharmaceutical Composition Comprising an Anti-IL-6 Receptor AntibodyFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2021·Application pending·0 cites
- 2758US2017020960A1Liquid formulations of tumor necrosis factor-binding proteinsARES TRADING SA·Filed 2016·Application pending·0 cites
- 2856US9138403B2PEG-interferon-beta formulationsDEL RIO ALESSANDRA·Filed 2008·Granted Sep 22, 2015·0 cites·29 claims
- 2956US2021100903A1Aqueous pharmaceutical formulation comprising anti-pd-l1 antibody avelumabMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 3051US8664369B2LH liquid formulationsAGOSTINETTO RITA·Filed 2008·Granted Mar 4, 2014·0 cites·15 claims
- 3150US2010239580A1Taci-immunoglobulin fusion proteins for treatment of optic neuritisAREA TRADING S A·Filed 2008·Application pending·0 cites
- 3245US8309069B2Human serum albumin-free stabilized interferon liquid formulationsSAMARITANI FABRIZIO·Filed 2004·Granted Nov 13, 2012·0 cites·15 claims
- 3342US2020016267A1Aqueous anti-pd-l1 antibody formulationMERCK PATENT GMBH·Filed 2018·Application pending·0 cites
- 3437US2016228374A1Freeze-dried formulations of fgf-18ARES TRADING SA·Filed 2016·Application pending·0 cites
- 3536US10959939B2Liquid pharmaceutical composition of etanercept with lysine and prolineARES TRADING SA·Filed 2015·Granted Mar 30, 2021·0 cites·10 claims
- 3636US2018296674A1Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alessandra Del Rio files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →